window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-108383172-1');

Know the symptoms, but don’t wait to get screened

Colorectal cancer progresses slowly and doesn’t show signs or symptoms until an advanced stage1. Thus,  people who get cancer are diagnosed late whereas an early detection increases the chances of survival. Even if we don’t have to wait for the first symptoms to get screened, it is important to recognize the signs that may be associated to colorectal cancer. In the article from Colorectal Cancer Alliance, you can find symptoms associated to colorectal cancer. The following disorders are cause for alarm. If you notice any symptoms don’t hesitate to make an appointment with your doctor.

For the full article :

> A Change in Bowel Habits
Including diarrhea, constipation, a change in the consistency of your stool or finding your stools are narrower than usual


> Persistent Abdominal Discomfort
Such as cramps, gas, or pain and/or feeling full, bloated or that your bowel does not empty completely


> Rectal Bleeding
Finding blood (either bright red or very dark) in your stool


> Weakness or Fatigue
Can also accompany losing weight for no known reason, nausea or vomiting


Colorectal cancer symptoms can also be associated with many other health conditions. Only a medical professional can determine the cause of your symptoms. Early signs of cancer often do not include pain. It is important not to wait before seeing a doctor. Early detection can save your life.


Cancer detection, survival rate & appearence of symptoms


 Most colorectal cancers develop slowly over several years. They often start as benign precursor lesions and develop over time into colorectal cancer. When detected early, colorectal cancer is highly curable and may be prevented through removal of precursor lesions known as adenomatous polyps. Over 90% of patients diagnosed at this early stage can survive the disease. However, if left untreated, the cancer will spread, reducing the survival rate to 70%. Once the cancer metastasizes the survival rate is further reduced to 8%2.
By |2018-06-14T16:19:16+02:0023 May 2018|Prevention|

About the Author:

Novigenix is an innovative Swiss molecular diagnostics company specializing in new generation blood tests for early detection of cancer. Colox®, our lead product is a proven molecular blood test designed to significantly reduce mortality from colorectal cancer through early detection and follow-up colonoscopy. Novigenix’s technology is based on a new generation of predictive gene expression profiles of circulating blood cells and concentration profile of tumor-derived protein markers in combination with state-of-the-art mathematical analytical models. Our predictive molecular signatures of biomarkers provide new and accurate solutions for the early detection of cancer.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Privacy Notice